SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-148073
Filing Date
2017-04-28
Accepted
2017-04-28 16:02:09
Documents
4
Period of Report
2017-06-07
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d256509ddef14a.htm DEF 14A 515968
2 GRAPHIC g256509dsp4.jpg GRAPHIC 95682
3 GRAPHIC g256509dsp5.jpg GRAPHIC 82366
4 GRAPHIC g256509g50h00.jpg GRAPHIC 26289
  Complete submission text file 0001193125-17-148073.txt   798454
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36544 | Film No.: 17795323
SIC: 2834 Pharmaceutical Preparations